R53H (p.Arg53His) variant of NFKBIA (NF-kappa-B inhibitor alpha)

R53H (p.Arg53His) in NFKBIA (NF-kappa-B inhibitor alpha) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Ectodermal dysplasia and immunodeficiency 2. The available variant effect predictions contribute to a CATVariant prioritization score of 0.39 / 1. The record also includes population frequency data and structural context.

R53H (p.Arg53His) variant details